The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates

Area of Science:

• Gerontology
• Muscle Physiology
• Clinical Diagnostics

Background:

• Sarcopenia, characterized by low muscle mass and weakness, is a prevalent and potentially disabling condition in older adults.
• Establishing clinically relevant and validated diagnostic criteria is essential for recognizing sarcopenia as a clinical condition.
• The Foundation for the National Institutes of Health (NIH) Biomarkers Consortium Sarcopenia Project employed an evidence-based methodology to develop these criteria.

Purpose of the Study:

• To develop and validate evidence-based diagnostic criteria for sarcopenia in older adults.
• To establish clinically relevant thresholds for low muscle mass and weakness.
• To guide the identification of participants for clinical trials and research studies.

Main Methods:

• Utilized data from nine diverse sources of community-dwelling older individuals, including large cohort studies and clinical trials.
• Incorporated feedback from conference attendees through surveys and breakout groups to refine criteria.
• Performed pooled analyses on a large dataset to determine final recommended cutpoints.

Main Results:

• The study analyzed data from 26,625 participants (57% women), with mean ages of 75.2 years for men and 78.6 years for women.
• Recommended cutpoints for weakness were established as grip strength <26kg for men and <16kg for women.
• Recommended cutpoints for low lean mass, adjusted for body mass index, were determined as appendicular lean mass <0.789 for men and <0.512 for women.

Conclusions:

• The developed evidence-based cutpoints provide a standardized approach to identifying sarcopenia in large, diverse populations.
• These criteria can aid in the selection of participants for clinical trials investigating sarcopenia.
• Further evaluation of these cutpoints in populations with high functional limitations is recommended.